Table 3.
Pharmacokinetic parameters | Free ADHC (3 mg/kg) | Free ADHC (9 mg/kg) | ADHC-L (3 mg/kg) |
---|---|---|---|
t1/2α (h) | 0.08±0.04 | 1.33±0.18** | 1.86±0.24** |
t1/2β (h) | 28.71±6.04 | 26.14±10.61 | 195.44±36.62** |
Kel (h−1) | 0.09±0.01 | 0.12±0.10* | 0.09±0.01 |
CL (L/h/kg) | 0.07±0.02 | 0.13±0.01* | 0.02±0.01* |
Vss (L/kg) | 0.80±0.18 | 1.08±0.05 | 0.20±0.01* |
MRT (h) | 32.06±4.47 | 32.10±13.02 | 273.97±58.00** |
AUC0–24 h (mg⋅h/L) | 20.69±1.10 | 52.91±0.37*** | 106.22±1.60*** |
AUC0–∞ (mg⋅h/L) | 42.00±12.49 | 67.29±1.18 | 163.80±24.03** |
Notes: Given values are mean ± SD (n=4).
P<0.05
P<0.01
P<0.001 versus free ADHC (3 mg/kg) treatment.
Abbreviations: ADHC, amiodarone hydrochloride; ADHC-L, amiodarone hydrochloride-loaded liposome; AUC, area under the concentration–time curve; CL, clearance; Kel, elimination rate constant; MRT, mean residence time; SD, standard deviation; t1/2α, half-life of distribution phase; t1/2β, half-life of elimination phase; Vss, steady-state distribution volume.